LON:APH Alliance Pharma (APH) Share Price, News & Analysis GBX 64.70 0.00 (0.00%) As of 05/14/2025 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Alliance Pharma Stock (LON:APH) Get Alliance Pharma alerts:Sign Up Key Stats Today's Range 64.70▼ 64.7050-Day Range 64.70▼ 64.7052-Week Range 30.50▼ 66.20VolumeN/AAverage Volume5.95 million shsMarket Capitalization£350.31 millionP/E RatioN/ADividend Yield3.75%Price TargetN/AConsensus RatingN/A Company Overview Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom. Read More Receive APH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alliance Pharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. APH Stock News HeadlinesRBC Capital Reaffirms Their Hold Rating on Alliance Pharma (APH)March 11, 2025 | markets.businessinsider.comAlliance Pharma Valued at $468 Million Under Increased Offer From Aegros BidcoMarch 10, 2025 | marketwatch.com$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO… | Paradigm Press (Ad)Alliance Pharma agrees £362m takeover by biggest shareholderMarch 10, 2025 | msn.comUK's Alliance Pharma agrees to final cash offer from asset management firm DBAYMarch 10, 2025 | reuters.comAlliance Pharma And 2 Other UK Penny Stocks With Promising FundamentalsFebruary 27, 2025 | finance.yahoo.comAlliance Pharma Expected Revenue Falls on Consumer Healthcare DeclineJanuary 31, 2025 | marketwatch.comAlliance Pharma Regulatory NewsJanuary 31, 2025 | lse.co.ukSee More Headlines APH Stock Analysis - Frequently Asked Questions How have APH shares performed this year? Alliance Pharma's stock was trading at GBX 64.70 at the start of the year. Since then, APH shares have increased by 0.0% and is now trading at GBX 64.70. How were Alliance Pharma's earnings last quarter? Alliance Pharma plc (LON:APH) announced its earnings results on Tuesday, April, 8th. The company reported $4.32 earnings per share (EPS) for the quarter. Alliance Pharma had a negative net margin of 6.00% and a negative trailing twelve-month return on equity of 5.04%. How do I buy shares of Alliance Pharma? Shares of APH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Alliance Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Alliance Pharma investors own include boohoo group (BOO), BP (BP), Vodafone Group Public (VOD), Aviva (AV), Babcock International Group (BAB), BAE Systems (BA) and The Gym Group (GYM). Company Calendar Last Earnings4/08/2025Today5/26/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryElectronic Equipment Current SymbolLON:APH CIKN/A Webwww.alliancepharma.co.uk Phone+44-1249-466966FaxN/AEmployees91,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (6.20) Trailing P/E RatioN/A Forward P/E Ratio12.47 P/E Growth1.04Net Income-£33.65 million Net Margins-6.00% Pretax MarginN/A Return on Equity-5.04% Return on Assets5.98% Debt Debt-to-Equity Ratio46.09 Current Ratio2.84 Quick Ratio1.42 Sales & Book Value Annual Sales£183.50 million Price / Sales1.91 Cash FlowGBX 8.22 per share Price / Cash Flow7.87 Book ValueGBX 41.25 per share Price / Book1.57Miscellaneous Outstanding Shares541,444,969Free FloatN/AMarket Cap£350.31 million OptionableNot Optionable Beta0.67 10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report This page (LON:APH) was last updated on 5/27/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alliance Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Alliance Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
